Dermatology Times is recapping our top expert interviews from the month of April.
Shahriari shares pearls and considerations from her sessions at the recent Diversity in Dermatology conference.
Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.
In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.
Gil Yosipovitch, MD, discusses the correlation between increased BNP levels and chronic pruritus of unknown origin.
Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.
Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.
Miranti presented tips on handling denial hurdles and how to ensure patients receive access to the treatments they need.
Noor, the co-owner of Rao Dermatology, shares about his interests in dermatology and what he most looks forward to as a member of our board.
Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.
Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
Hasbargen presented Mohs surgery pearls on closure types and pattern recognition at the 2024 Diversity in Dermatology meeting.
Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.
Mona Shahriari, MD, and a plaque psoriasis patient provide insights into the mechanism of action and benefits of tapinarof cream 1% as a nonsteroidal topical.
Don’t miss a moment of Dermatology Times by signing up for our
